Skip to content

Insider · CIK 0001662170

John Militello

officer

Files at RCKT (ROCKET PHARMACEUTICALS, INC.). First filing Nov 4, 2024, latest Nov 20, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 9
$0 bought, $185k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

RCKT: ROCKET PHARMACEUTICALS, INC.

RCKTOct 9, 2026 · close 2.56

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
RCKTsell 4
ROCKET PHARMACEUTICALS, INC.
$3,240
1,086 shares
-2%+26% from low-80% from high
35Weak
RCKTsell
ROCKET PHARMACEUTICALS, INC.
$115k
28,918 shares
-30%+83% from low-77% from high
30Weak
RCKTsell 3
ROCKET PHARMACEUTICALS, INC.
$3,224
1,060 shares
-2%+30% from low-86% from high
35Weak
RCKTsell 3
ROCKET PHARMACEUTICALS, INC.
$21k
7,043 shares
-11%+30% from low-86% from high
30Weak
RCKTsell 5
ROCKET PHARMACEUTICALS, INC.
$2,301
357 shares
-1%+43% from low-69% from high
30Weak
RCKTsell 5
ROCKET PHARMACEUTICALS, INC.
$4,276
655 shares
-1%+36% from low-70% from high
15Weak
RCKTsell
ROCKET PHARMACEUTICALS, INC.
$5,139
718 shares
-1%+46% from low-68% from high
30Weak
RCKTsell 4
ROCKET PHARMACEUTICALS, INC.
$16k
1,224 shares
-2%-
23Weak
RCKTsell 2
ROCKET PHARMACEUTICALS, INC.
$15k
917 shares
-2%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,086$2.98$3,24065,920Nov 20, 2025
Oct 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-19,841$3.96$79k76,083Oct 16, 2025
Oct 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-5,514$3.97$22k70,569Oct 16, 2025
Oct 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-3,005$3.97$12k67,564Oct 16, 2025
Oct 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-558$3.98$2,21867,006Oct 16, 2025
Sep 8, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
AGrant or award
Common Stock
+40,000$0.00$095,924Sep 9, 2025
Aug 18, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-699$3.07$2,14256,285Aug 20, 2025
Aug 19, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-361$3.00$1,08255,924Aug 20, 2025
Aug 14, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-7,043$3.02$21k56,984Aug 18, 2025
May 20, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-357$6.45$2,30164,027May 22, 2025
May 16, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-655$6.53$4,27664,384May 20, 2025
Apr 22, 2025RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-718$7.16$5,13965,039Apr 24, 2025
Nov 21, 2024RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-1,224$13.05$16k49,310Nov 25, 2024
Oct 31, 2024RCKT
ROCKET PHARMACEUTICALS, INC.
SOpen-market sale
Common Stock
-917$16.63$15k50,534Nov 4, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

John Militello: insider trades and track record | InsiderTell